ライフサイエンスコーパス: lymph node

1 disease correctly identified in the sentinel lymph node.

2 endritic cells of the metastasis-infiltrated lymph node.

3 piration of a palpable, ipsilateral axillary lymph node.

4 36 of whom had at least one mapped sentinel lymph node.

5 ent lymph nodes and 1 pig exhibited a single lymph node.

6 d to calculate the amount of dye within each lymph node.

7 enal antigens to CD8 T cells in the draining lymph node.

8 fewer DCs carrying parasite antigens to the lymph nodes.

9 cantly between metastatic and non-metastatic lymph nodes.

10 nd meninges to the peripheral (CNS-draining) lymph nodes.

11 ongly correlated with metastasis to lung and lymph nodes.

12 cord while wild type DC migrated to cervical lymph nodes.

13 survival of central memory T (TCM) cells in lymph nodes.

14 reduction in IL-17(+) cells in the draining lymph nodes.

15 ation of the immune response in the draining lymph nodes.

16 ultiple tissues in patients, particularly in lymph nodes.

17 spensable for their activation in pancreatic lymph nodes.

18 occurred only in the regional skin-draining lymph nodes.

19 prefer to metastasize to lung rather than to lymph nodes.

20 kine secretion and proliferation in regional lymph nodes.

21 y a major role in viral reservoir control in lymph nodes.

22 before leaving the inflamed skin to draining lymph nodes.

23 ed in duodenum, ileum, colon, and mesenteric lymph nodes.

24 ed role of the receptor in guiding exit from lymph nodes.

25 emory CD4(+) T cells in peripheral blood and lymph nodes.

26 mphangiogenesis in intestinal lesions and in lymph nodes.

27 airway lumen into lung-draining paratracheal lymph nodes.

28 eens, pancreatic lymph nodes (pLN) and other lymph nodes.

29 ine injection site, but not vaccine-draining lymph nodes.

30 atic drainage from the CNS to the peripheral lymph nodes.

31 flow cytometry in the lungs and paratracheal lymph nodes.

32 onal imaging for the detection of metastatic lymph nodes.

33 nd promote Th2, but not Th17, development in lymph nodes.

34 tumor status in order to identify metastatic lymph nodes.

35 n exam, and multiple palpable right axillary lymph nodes.

36 4(lo)Foxp3(+) central Treg cells in draining lymph nodes.

37 ells were detected in local genital draining lymph nodes.

38 sitively correlates with local metastases in lymph nodes.

39 ) IFN-gamma(+) T cells in the heart-draining lymph nodes.

40 acrophage M1-like polarization within murine lymph nodes.

41 ophil trafficking from lungs to paratracheal lymph nodes.

42 ial AT, which outnumbered DCs and T cells in lymph nodes.

43 lated from tonsils, gut mucosa, and draining lymph nodes.

44 ale for surgical resection of tumor-draining lymph nodes.

45 s CTVs were bone (23/52, 44%) and perirectal lymph nodes (16/52, 31%).

46 on therapy to the primary tumor and regional lymph nodes (45 to 54 Gy) plus eight once-weekly doses o

47 ral DNA levels in PBMCs after 2 weeks and in lymph nodes after 10 weeks.

48 , retropharyngeal lymph node, nasopharyngeal lymph node and pharyngeal tonsil collected at the peak o

49 ongitudinal intravital imaging of the murine lymph node and surrounding structures for up to 14 d.

50 odes were detected; 2 pigs had 2 fluorescent lymph nodes and 1 pig exhibited a single lymph node.

51 exhibited reduced lymphocyte trafficking to lymph nodes and a corresponding increase in T cell popul

52 but were barely detectable within noninvaded lymph nodes and absent in peripheral blood.

53 Association of SNTI in sentinel lymph nodes and BMM in patients with stage I to III colo

54 ncies of ZIKV-specific Ab-secreting cells in lymph nodes and bone marrow, correlating with low Ab tit

55 re present in para-aortic adipose tissue and lymph nodes and display an inflammatory-like phenotype a

56 homing of tumor-infiltrating DC to draining lymph nodes and increased infiltration of T cells into t

57 it the entry of circulating lymphocytes into lymph nodes and long-term parabiosis experiments, we hav

58 ositively correlated with enlargement of the lymph nodes and peaked on day 10 postinfection.

59 secondary lymphoid organs, including spleen, lymph nodes and Peyer's patches, where T cells search fo

60 ilar to DCs, they homeostatically migrate to lymph nodes and present antigen to antigen-specific T ce

61 4 production by CD4(+) T cells isolated from lymph nodes and prevented IgE-dependent oral allergen-in

62 sustained on allergen recall response in the lymph nodes and spleen.

63 uripotency and the ability to migrate to the lymph nodes and spleen.

64 +) DCs, which enhances migration to draining lymph nodes and Th2 priming capacity.

65 In particular, they could shuttle between lymph nodes and the CNS and produced encephalitogenic cy

66 These cells traffic between lymph nodes and the skin, and are identified by their co

67 are trapped for long periods of time within lymph nodes and the spleen in the steady state.

68 x transcription factor (T-bet)(+) B cells in lymph nodes, and an accumulation of T-bet(+)CD21(low) B

69 e tumor cells can escape into the blood, the lymph nodes, and at times the visceral organs.

70 oE(-/-)Irf5(-/-) mice in the aorta, draining lymph nodes, and bone marrow cell cultures, indicating t

71 hearts, pericardial AT, spleen, mediastinal lymph nodes, and bone marrow were quantified by flow cyt

72 eural invasion, R1 resections, more positive lymph nodes, and higher lymph node ratios (P < 0.05).

73 , with occasional viremia; tonsil, mesentery lymph nodes, and intestinal mucosa served as major targe

74 neck disease, increasing number of positive lymph nodes, and lower neck disease.

75 -day mortality, the total number of resected lymph nodes, and R0 resection rates was evaluated with m

76 e 30-day mortality, total number of resected lymph nodes, and R0 resection rates.

77 ed for (99m)Tc activity, which established a lymph node as an SLN.

78 uNP that targeted myeloid dendritic cells in lymph nodes as a peptide antigen carrier, substantially

79 103(+) dendritic cells, in the lung-draining lymph node, as well as increased expression of the costi

80 rine melanoma cell line highly metastatic to lymph nodes (B16F10) was implanted subcutaneously on the

81 rimary endpoint, sensitivity of the sentinel-lymph-node-based detection of metastatic disease, was de

82 the results clearly identified the sentinel lymph node basin and delineated the lymphatic drainage.

83 astatic lesions in the liver, bone, lung, or lymph nodes before and after Sandostatin LAR administrat

84 precisely BCL2-IGH translocations present in lymph node biopsies of follicular lymphoma patents.

85 Observations: Sentinel lymph node biopsy (SLNB) after NAC in patients presentin

86 concerting lymphedema rates in both sentinel lymph node biopsy (SLNB) and axillary lymph node dissect

87 inical trials will evaluate whether sentinel-lymph-node biopsy can be avoided altogether in selected

88 or staging has now been replaced by sentinel-lymph-node biopsy for patients with clinically negative

89 Refinement of the sentinel-lymph-node biopsy technique might overcome the slightly

90 spite extensive sampling from ileum, rectum, lymph nodes, bone marrow, CSF, circulating CD4+ T cell s

91 seminal vesicles, local lymph nodes, distant lymph nodes, bone, and others) at both time points by vi

92 al vesicle, or extraprostatic, including all lymph nodes, bone, or soft-tissue metastasis), and subje

93 68% of lungs and 36% of spleens and cervical lymph nodes but fewer than 20% of axillary lymph nodes,

94 tromal cells regulate leukocyte responses in lymph nodes, but the role of stromal cells in adipose ti

95 sent within tumors and invaded or metastatic lymph nodes, but were barely detectable within noninvade

96 he extension of neoplastic cells through the lymph node capsule into the perinodal adipose tissue.

97 was observed in ex vivo culture of cervical lymph node cells and splenocytes, indicating that in all

98 (+) T cells and IL-5 and IL-13 production by lymph node cells but had no effect on IgE production.

99 Lymph node cells from untreated HIV-infected individuals

100 into account the number of involved axillary lymph nodes, clinical tumour stage, oestrogen-receptor s

101 of peripheral activation events in cervical lymph nodes (CLN) to driving humoral immune responses in

102 intestinal lamina propria (LPL) and cervical lymph nodes (CLN).

103 ype of cancer with an inherent potential for lymph node colonization, which is generally preceded by

104 lithiasis, infiltration, biliary dilatation, lymph nodes, complications.

105 None of the three sentinel lymph nodes contained metastatic carcinoma.

106 Two of the 11 axillary lymph nodes contained metastatic carcinoma.

107 ble axillary adenopathy, and 1 or 2 sentinel lymph nodes containing metastases, 10-year overall survi

108 ble axillary adenopathy, and 1 or 2 sentinel lymph nodes containing metastases.

109 stics were not improved with the addition of lymph node CT morphology criteria.

110 Mesenteric lymph node cultures from VDR KO and B-VDR KO mice secret

111 C(+) macrophages in the ankles and popliteal lymph nodes, decreased migration of monocytes into the a

112 prove this concept, trans-/intramucosal and lymph-node delivery of PLGA-PEG nanoparticles was demons

113 duction in peripheral CD4 memory T cells and lymph node-derived follicular helper T cells of patients

114 excessive IFN-gamma production by blood and lymph node-derived T cells of patients with CVID with im

115 roarray in Node-Negative and 1 to 3 Positive Lymph Node Disease May Avoid Chemotherapy) study to eval

116 ode dissection (SLND) alone without axillary lymph node dissection (ALND) is noninferior to that of w

117 ntinel lymph node biopsy (SLNB) and axillary lymph node dissection (ALND) may be because of unrecogni

118 (SLN) metastases should not receive axillary lymph node dissection (ALND).

119 entinel node biopsy (SNB) to extended pelvic lymph node dissection (ePLND) remains controversial.

120 Minimally invasive inguinal lymph node dissection (MILND) is a novel approach to ing

121 with breast-conserving therapy and sentinel lymph node dissection (SLND) alone without axillary lymp

122 survival for patients treated with sentinel lymph node dissection alone was noninferior to overall s

123 front SLNB and reduces the need for axillary lymph node dissection compared with SLNB prior to NAC.

124 dings do not support routine use of axillary lymph node dissection in this patient population based o

125 We have previously found that axillary lymph node dissection, both clinically and in a mouse mo

126 y followed by radical cystectomy with pelvic lymph node dissection, which disclosed residual high-gra

127 ed by breast-conserving surgery and axillary lymph node dissection, which revealed residual disease i

128 all survival for those treated with axillary lymph node dissection.

129 may require chemotherapy, radiotherapy, and lymph node dissection.

130 rker molecular assay to immediate completion lymph-node dissection (dissection group) or nodal observ

131 -lymph-node involvement, completion axillary-lymph-node dissection can be omitted or replaced by axil

132 The value of completion lymph-node dissection for patients with sentinel-node me

133 viously undisputed gold standard of axillary-lymph-node dissection for staging has now been replaced

134 Immediate completion lymph-node dissection was not associated with increased

135 locations (prostate, seminal vesicles, local lymph nodes, distant lymph nodes, bone, and others) at b

136 d localization with, T cells in the draining lymph node (dLN).

137 the primary producer of IL-4 in the reactive lymph node during type 2 immune responses.

138 f the type 2 immune response in the reactive lymph nodes during parasitic helminth infection.

139 w in mice that local delivery of Rapa MPs to lymph nodes during vaccination either suppresses or enha

140 Despite the thymic and lymph node egress defects, sphingosine-1-phosphate signa

141 G uptake by day 4 postinfection with minimal lymph node enlargement, indicating that elevated cell me

142 endothelial venules and exhibited defects in lymph node entrance and egress.

143 Lobectomy with systematic lymph node evaluation remains the recommended treatment,

144 antigen-induced T cell expansion in draining lymph node experiments.

145 of NKT cells at the interfollicular areas of lymph nodes facilitates both their direct priming by res

146 uently CXCR5(+) and entered and persisted in lymph node follicles throughout the follow-up (240 d pos

147 to the chest wall and the draining regional lymph nodes, followed by an optional mastectomy scar boo

148 port a role of macrophage efflux to draining lymph nodes following treatment with infliximab.

149 livering antigens and soluble factors to the lymph node for immune surveillance.

150 diffusion coefficient (DWI/ADC) images of 86 lymph nodes from 31 cancer patients were analyzed.

151 eally injected eosinophils into paratracheal lymph nodes from distal alveolar lung was diminished in

152 d immune activation in vivo, was enhanced in lymph nodes from pigtailed macaques infected with simian

153 elper T cells, thymic T cell development and lymph-node genesis.

154 vere loss of dendritic cells in the draining lymph node had no impact on viral replication in this or

155 patients with adenocarcinoma, 41 (93.2%) had lymph nodes harvested, with nodal metastases in only 14

156 However, lymph node hyperplasia was clearly visible postviremia b

157 endritic cells and T cells into the draining lymph node immediately following infection and for the r

158 rostate bed in 27% of patients, locoregional lymph nodes in 39%, and distant metastatic disease in 16

159 nto the lung lumen, parenchyma, and draining lymph nodes in HDM-sensitized mice.

160 FDG followed by Cerenkov-guided resection of lymph nodes in healthy mice has previously been introduc

161 he airways and on DC subsets in the lung and lymph nodes in murine model of allergic airway inflammat

162 ary dendritic cells in the lung and draining lymph nodes in wild-type BALB/c mice after RSV infection

163 e in donor cells in the mediastinal draining lymph nodes; increased lymphatic vessel area; and graft

164 We developed a quantitative PCR-based lymph node infiltration assay to address the slowness of

165 Lymph node inflammation was higher in HIV-infected indiv

166 0 days or less (HR, 2.6; P = 0.01) and hilar lymph node invasion (HR = 2.2; P = 0.03), but not pre-LT

167 This may explain our findings of increased lymph node invasion and new metastatic sites in 30% of s

168 positive surgical margins, and/or pathologic lymph node invasion.

169 the pathological tumor stage and presence of lymph node invasion.

170 Nineteen of 26 lymph nodes involved by NLPHL demonstrated a population

171 l disease, T stage, resection margin status, lymph node involvement, and postoperative complications.

172 For selected patients with limited sentinel-lymph-node involvement, completion axillary-lymph-node d

173 gens to antigen-presenting cells in draining lymph nodes, leading to increased surface presentation w

174 itive for carcinoma in level 2, 3, 4R, and 7 lymph nodes; level 4L was negative.

175 In solid tumors, the presence of lymph node-like structures called tertiary lymphoid stru

176 phoid-tissue inducer (LTi) cells residing in lymph node-like structures in the gut called solitary in

177 cutaneous tumors were metastatic to regional lymph nodes, liver and lung.

178 l lymph nodes but fewer than 20% of axillary lymph nodes, livers, brown fat samples, kidneys, or bloo

179 cluded 17 patients with ipsilateral axillary lymph node (LN) metastases.

180 hanced computed tomography (CT) in detecting lymph node (LN) metastasis in high-risk endometrial canc

181 To identify indicators of lymph node (LN) metastasis in thin melanoma in a large,

182 DR and PD-1 were measured in blood (n = 48), lymph node (LN; n = 9), and rectal tissue (n = 17) from

183 T cells, were enriched in SIV DNA in blood, lymph nodes (LN), spleen, and gut, and contained replica

184 erns, highest in blood, bone marrow (BM), or lymph nodes (LN), with the frequency and function in blo

185 ells underwent several divisions in draining lymph nodes (LN; DLNs) while maintaining expression of T

186 pathogenic, B cells rapidly increase in both lymph nodes (LNs) and intestine.

187 reticular cells (FRCs) in the T cell zone of lymph nodes (LNs) are pivotal for T cell survival, mobil

188 ent co-delivery of CpG and antigens (Ags) to lymph nodes (LNs) by albumin/AlbiVax than benchmark inco

189 or required for homing to GCs) and expand in lymph nodes (LNs) following pathogenic SIV infection in

190 f primary tumour and locoregional metastatic lymph nodes (LNs) in breast cancer and to look for poten

191 zation of MHCII-bound peptides isolated from lymph nodes (LNs) of C57BL/6 mice.

192 .25-294 ng/mL), 362 (68)Ga-PSMA PET-positive lymph nodes (LNs) were identified.

193 The NQF endorses evaluating >/=12 lymph nodes (LNs), adjuvant chemotherapy (AC) for stage

194 osal tissues (lungs, intestines), associated lymph nodes (LNs), and other lymphoid sites from 78 indi

195 activation are asymmetrically distributed in lymph nodes (LNs), but how this affects adaptive respons

196 n HIV, inflammation is also increased within lymph nodes (LNs), tissues known to harbor the virus eve

197 7 drives leukocyte migration into and within lymph nodes (LNs).

198 ion of cellular immune responses in draining lymph nodes (LNs).

199 t the stomach, with metastases documented in lymph nodes, lung, and liver.

200 lude intestinal lymphangiectasia, mesenteric lymph node lymphadenopathy, and lymphangiogenesis in bot

201 n from the iliac crests and in vivo sentinel lymph node mapping were performed during open standard o

202 situ hybridization, fluorescence imaging for lymph node mapping, nonmalignant lesions, nonsurgical pu

203 injection of indocyanine green and sentinel-lymph-node mapping followed by pelvic lymphadenectomy wi

204 Sentinel-lymph-node mapping has been advocated as an alternative

205 de-positive disease with successful sentinel-lymph-node mapping who had metastatic disease correctly

206 Sentinel-lymph-node mapping with complete pelvic lymphadenectomy

207 c vessels and lymph drainage into mesenteric lymph nodes may be compromised.

208 ed UNO (FAM-UNO) homed to tumor and sentinel lymph node MEMs in different cancer models: 4T1 and MCF-

209 ignificantly associated with the presence of lymph node metastases and invasive tumor stages.

210 platin-based chemotherapy, and it eliminated lymph node metastases by targeting CSCs and the tumor bu

211 r overall survival of patients with sentinel lymph node metastases treated with breast-conserving the

212 -DCFPyL and (18)F-PSMA-1007 for local tumor, lymph node metastases, and bone metastases.

213 tudy population was limited to patients with lymph node metastases, tumors 4 cm or larger, or local e

214 h disease progression and a higher number of lymph node metastases.

215 ive, early-stage breast cancer without overt lymph node metastases.

216 abolism between the primary PDTX and distant lymph node metastases.

217 colorectal cancers that was associated with lymph-node metastases (INHBB, AXL, FGFR1, and PDFGRB) an

218 with stage III cutaneous melanoma (excluding lymph node metastasis </=1 mm or in-transit metastasis)

219 e positively correlated with invasion depth, lymph node metastasis and negatively correlated with the

220 encoding cIAP1 and cIAP2, is associated with lymph node metastasis and poor clinical outcome in OSCC.

221 To ascertain the roles of cIAP1/cIAP2 in lymph node metastasis and radioresistance, we use an in

222 asis (CRLM), intrahepatic lymph invasion and lymph node metastasis are poor prognostic factors.

223 difference between pulmonary metastasis and lymph node metastasis showing that the androgen receptor

224 h aggressive features that include increased lymph node metastasis, reduced responsiveness to neoadju

225 relation of 11q22.1-q22.2 amplification with lymph node metastasis, reduced survival, and increased c

226 ntly associated with histological grades and lymph node metastasis.

227 entral tumour, the tumour invasive front and lymph node metastasis.

228 tively correlated with tumor stage, size and lymph node metastasis.

229 but (68)Ga-PSMA-11 PET/CT showed additional lymph nodes metastasis.

230 ration but no apoptosis, presenting frequent lymph-node metastasis.

231 tokine, and Tgfbeta expression in mesenteric lymph node (MLN) CD4(+) T cells and jejunum were monitor

232 ration were largely found in the mediastinal lymph node (mLN), rather than the airways; however, cell

233 er of the primary lesion (T), of the largest lymph node (N), and of the largest metastatic lesion (M)

234 psy sites were bone (n = 7), pleura (n = 3), lymph nodes (n = 2), and liver (n = 2).

235 issues bronchial lymph node, retropharyngeal lymph node, nasopharyngeal lymph node and pharyngeal ton

236 erall survival of lymph node-positive versus lymph node-negative patients decreased significantly fro

237 l metastases were identified in the sentinel lymph nodes of 35 (97%) of these 36 patients, yielding a

238 T (Tfh) cells were also detected in draining lymph nodes of allergic mice.

239 ed in CD4+ T cells isolated from spleens and lymph nodes of arthritic mice treated with CM-MSC or MSC

240 resulted in detectable virus in brain and/or lymph nodes of fetuses and/or pups.

241 maintain the Th2 response in the mesenteric lymph nodes of infected mice.

242 ation of viral Gag and CD169 was observed in lymph nodes of infected pigtailed macaques, suggesting p

243 ioned the in vivo mobilization to mesenteric lymph nodes of intestinal migratory CD103(+) DCs carryin

244 In contrast, the bone marrow and lymph nodes of nonsurvivors showed increased [(18)F]-FDG

245 G35-55-specific T cells in the skin draining lymph nodes of primed mice, but it is not required for t

246 In lymph nodes of surviving monkeys, changes in [(18)F]-FDG

247 involvement (M1a or M1b due to extrathoracic lymph nodes only) or disseminated metastatic disease.

248 haalpha T cells, and CD8alphabeta T cells in lymph nodes, peripheral blood, and bronchoalveolar lavag

249 The lymph node periphery is an important site for many immun

250 cell migration from the skin to the draining lymph nodes plays a prominent role in activating systemi

251 +) and CD8(+) T cells in spleens, pancreatic lymph nodes (pLN) and other lymph nodes.

252 eral blood (PB) and from pancreatic draining lymph nodes (PLN) of T1D patients and non-diabetic subje

253 on therapy to the primary tumor and regional lymph nodes plus eight once-weekly doses of concurrent c

254 .01), but a higher proportion of cases with lymph nodes positive for cancer (40.9% [442 of 1080] vs

255 %, the hazard ratios for overall survival of lymph node-positive versus lymph node-negative patients

256 n of any age with hormone receptor-positive, lymph node-positive, and operable breast cancer for whic

257 squamous cell carcinoma of the anus (SCCA), lymph node positivity (LNP) indicates poor prognosis for

258 ent age is an important factor in estimating lymph node positivity in thin melanoma independent of tr

259 n-free survival was similar in patients with lymph node PR or CR by IWCLL criteria.

260 K) cells are located at the periphery of the lymph node, predominantly in the medulla, and we found t

261 rivesical fat and involving two of 20 pelvic lymph nodes (pT3N2).

262 tions, more positive lymph nodes, and higher lymph node ratios (P < 0.05).

263 Lymph node recurrence following CRLM resection was assoc

264 However, sentinel lymph node removal does not necessarily extend the overa

265 es was distinct and could be used for guided lymph node resection, such as by using Cerenkov luminesc

266 ) and 54 (67%) metastatic and non-metastatic lymph nodes, respectively.

267 Absolute lymph node retrieval was not related to survival (P = 0.

268 CI, 0.34-3.67; P = .86), the mean number of lymph nodes retrieved (mean difference, 0.05; 95% CI, -0

269 esions and in the lymphoid tissues bronchial lymph node, retropharyngeal lymph node, nasopharyngeal l

270 ing of migrating T cells in the steady-state lymph node revealed both cell-wide and localized sub-cel

271 fied PCV3 antigen in skin, kidney, lung, and lymph node samples localized in typical PDNS lesions, in

272 The number of positive lymph nodes seems to be an appropriate selection factor

273 wed amelioration of lymphoproliferation with lymph node sizes and spleen volumes reduced by 39% (mean

274 rgical Oncology (SSO) guideline for sentinel lymph node (SLN) biopsy in melanoma.

275 Conclusion Women without sentinel lymph node (SLN) metastases should not receive axillary

276 ductions in bacterial burden in the draining lymph nodes, spleen, and liver were observed.

277 A better EFS was associated with negative lymph node status ( P < .01) and absence of LOH 1p or 16

278 only 74% in patients with combined positive lymph node status and LOH 1p or 16q.

279 leason grade, pathological T score, positive lymph node status and primary therapy failure.

280 dent changes in RNA profiles of the draining lymph node, suggesting a change in cell profile followin

281 that WNV may migrate from the skin into the lymph node through another mechanism.

282 e out of the skin and mucosa to the draining lymph nodes to present antigens to T and B cells.

283 In selected mice, popliteal lymph nodes underwent Cerenkov luminescence imaging.

284 es from the oral cavity, larynx-pharynx, and lymph nodes using 16S rRNA sequencing.

285 c CD8(+) T cells were detected in the blood, lymph nodes, vagina, cervix, uterus, and fallopian tubes

286 n detection and identification of metastatic lymph nodes was distinct and could be used for guided ly

287 inhibition, positing that efflux to draining lymph nodes was involved.

288 T cells subsets in blood, spleen and lymph nodes were detected dynamically by flow cytometry.

289 A total of 5 fluorescent lymph nodes were detected; 2 pigs had 2 fluorescent lymp

290 the intestinal lamina propria and mesenteric lymph nodes were GFP(+) However, in vitro infection of t

291 The six dissected lymph nodes were negative for malignancy.

292 Several peripancreatic lymph nodes were observed that measured up to 11 mm x 5

293 Sentinel lymph nodes were successfully detected in all patients.

294 essing melanocytes localize to skin-draining lymph nodes, where they induce T-cell proliferation and

295 phatic flow from the donor graft to draining lymph nodes, which may be a factor in promoting cellular

296 ll responses within the local draining iliac lymph nodes, yet robust Th1 and Th17 responses were prom

297 To evaluate the impact of lymph node yield (LNY) on survival in patients treated w

298 Lymph node yield has been used as a surrogate for extent

299 Outcomes according to lymph node yield were determined.

300 or positive resection margins, and >/=23 for lymph node yield.